{
"NDC": {
"NDCCode": "33342-248-44",
"PackageDescription": "1000 TABLET in 1 BOTTLE (33342-248-44) ",
"NDC11Code": "33342-0248-44",
"ProductNDC": "33342-248",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Repaglinide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Repaglinide",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20230322",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA207209",
"LabelerName": "Macleods Pharmaceuticals Limited",
"SubstanceName": "REPAGLINIDE",
"StrengthNumber": ".5",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Glinide [EPC], Potassium Channel Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2023-04-06",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20230322",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}